143 related articles for article (PubMed ID: 32223683)
1. An overview of stereotactic body radiation therapy for hepatocellular carcinoma.
Kimura T; Doi Y; Takahashi S; Kubo K; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Murakami Y; Kenjo M; Nagata Y
Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):271-279. PubMed ID: 32223683
[No Abstract] [Full Text] [Related]
2. Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.
Bettinger D; Gkika E; Schultheiss M; Glaser N; Lange S; Maruschke L; Buettner N; Kirste S; Nestle U; Grosu AL; Thimme R; Brunner TB
BMC Cancer; 2018 Aug; 18(1):807. PubMed ID: 30092781
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Dumago MP; Agas RAF; Jainar CJE; Yap ET; Co LBA; Ortin TTS
J Gastrointest Cancer; 2023 Dec; 54(4):1058-1070. PubMed ID: 37306936
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Outcome of Stereotactic Body Radiotherapy for Small Hepatocellular Carcinoma Lesions - A Systematic Review and Network Meta-analysis.
Li LQ; Su TS; Wu QY; Lin ZT; Liang SX
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):652-664. PubMed ID: 37541936
[TBL] [Abstract][Full Text] [Related]
5. Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.
Abualnil AY; Kumar R; George MA; Lalos A; Shah MM; Deek MP; Jabbour SK
Surg Oncol Clin N Am; 2024 Jan; 33(1):173-195. PubMed ID: 37945142
[TBL] [Abstract][Full Text] [Related]
6. Treatment of localized hepatocellular carcinoma: resection vs. ablation vs. radiation.
Anderson C; Chin HM; Hoverson J; Court C; Wagner T; Newman NB
Ann Palliat Med; 2024 Mar; 13(2):344-354. PubMed ID: 38373778
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression.
Malik A; Jairam MP; Chow R; Mirshahvalad SA; Veit-Haibach P; Simone CB
Future Oncol; 2023 Feb; 19(4):279-287. PubMed ID: 36916490
[No Abstract] [Full Text] [Related]
8. Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.
Pollom EL; Lee K; Durkee BY; Grade M; Mokhtari DA; Wahl DR; Feng M; Kothary N; Koong AC; Owens DK; Goldhaber-Fiebert J; Chang DT
Radiology; 2017 May; 283(2):460-468. PubMed ID: 28045603
[TBL] [Abstract][Full Text] [Related]
9. Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma.
Mohamed M; Katz AW; Tejani MA; Sharma AK; Kashyap R; Noel MS; Qiu H; Hezel AF; Ramaraju GA; Dokus MK; Orloff MS
Adv Radiat Oncol; 2016; 1(1):35-42. PubMed ID: 28799575
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis.
Pan YX; Fu YZ; Hu DD; Long Q; Wang JC; Xi M; Liu SL; Xu L; Liu MZ; Chen MS; Zhang YJ
Front Oncol; 2020; 10():1639. PubMed ID: 33194569
[No Abstract] [Full Text] [Related]
11. Hypofractionation in Hepatocellular Carcinoma - The Effect of Fractionation Size.
Lewis S; Barry A; Hawkins MA
Clin Oncol (R Coll Radiol); 2022 May; 34(5):e195-e209. PubMed ID: 35314091
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes following surgical resection, percutaneous ablation or stereotactic body radiation therapy in early-stage, solitary and small (≤3 cm) treatment-naïve hepatocellular carcinoma.
Maher AM; Shanker M; Liu HYH; Lee Y; Leggett D; Hodgkinson P; Pryor D; Stuart KA
Cancer Med; 2024 Feb; 13(3):e6978. PubMed ID: 38400681
[TBL] [Abstract][Full Text] [Related]
13. Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study.
Moon AM; Kim HP; Singal AG; Owen D; Mendiratta-Lala M; Parikh ND; Rose SC; McGinty KA; Agala CB; Burke LM; Abate A; Altun E; Beyer C; Do J; Folkert MR; Forbes C; Hattangadi-Gluth JA; Hayashi PH; Jones K; Khatri G; Kono Y; Lawrence TS; Maurino C; Mauro DM; Mayo CS; Pak T; Patil P; Sanders EC; Simpson DR; Tepper JE; Thapa D; Yanagihara TK; Wang K; Gerber DA
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314737
[TBL] [Abstract][Full Text] [Related]
14. Challenges in imaging assessment following liver stereotactic body radiotherapy: pitfalls to avoid in clinical practice.
Yip C; Cook GJR; Owczarczyk K; Goh V
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S11. PubMed ID: 28917249
[TBL] [Abstract][Full Text] [Related]
15. Canine primary liver tumors treated with stereotactic body radiation therapy: A case series.
Chan QYP; Morrow D; Lurie D
Vet Radiol Ultrasound; 2024 Mar; 65(2):121-129. PubMed ID: 38279767
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment of HCC with SBRT and immune checkpoint inhibition.
Podesta C; Kayani M; Goody R; Samson A
Crit Rev Oncol Hematol; 2023 Dec; 192():104191. PubMed ID: 37865277
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma.
Jiang J; Diaz DA; Nuguru SP; Mittra A; Manne A
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612046
[TBL] [Abstract][Full Text] [Related]
18. Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer.
Keane FK; Hong TS
Cancer Control; 2017; 24(3):1073274817729242. PubMed ID: 28975835
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for liver tumors.
Keane FK; Tanguturi SK; Zhu AX; Dawson LA; Hong TS
Hepat Oncol; 2015 Apr; 2(2):133-146. PubMed ID: 30190993
[TBL] [Abstract][Full Text] [Related]
20. Large hepatocellular carcinoma treated with sequential SBRT and immunotherapy with anti-VEGF (Vascular Endothelial Growth Factor) therapy.
Bidarmaghz B; Idrees M; Lee YY; Hodgkinson P
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38061854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
